From: Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
Factors | Univariate analysis | ||
---|---|---|---|
HR | 95% CI | p-value | |
Cohort 1 | |||
 Age (≥ 50 vs. < 50) | 1.132 | 0.797–1.608 | .489 |
 Histologic grade (3 vs. 1 or 2) | 0.891 | 0.604–1.315 | .561 |
 Lymph node (positive vs. negative) | 2.281 | 1.609–3.232 |  < .001* |
 LVI (positive vs. negative) | 3.049 | 2.152–4.321 |  < .001* |
 pT (3 or 4 vs. 1 or 2) | 2.392 | 1.214–4.713 | .012* |
 Stage (2 or 3 vs. 1) | 1.740 | 1.155–2.621 | .008* |
 TILs (%) | 0.982 | 0.974–0.989 |  < .001* |
 TROP2 (H-score) | 1.001 | 0.998–1.003 | .510 |
 TROP2 (high vs. low) | 0.928 | 0.655–1.316 | .676 |
Cohort 2 | |||
 Age (≥ 50 vs. < 50) | 0.449 | 0.134–1.503 | .194 |
 Histologic grade (3 vs.1 or 2) | 1.361 | 0.543–3.408 | .511 |
 Lymph node (positive vs. negative) | 6.774 | 2.799–16.397 |  < .001* |
 LVI (positive vs. negative) | 3.294 | 1.494–7.261 | .003* |
 ypT (3 or 4 vs. 1 or 2) | 7.858 | 3.150–19.600 |  < .001* |
 Stage (2 or 3 vs. 1) | 7.075 | 2.416–20.713 |  < .001* |
 TILs (%) | 0.968 | 0.938–0.998 | .036* |
 TROP2 (H-score) | 1.002 | 0.995–1.008 | .621 |
 TROP2 (high vs. low) | 1.241 | 0.518–2.972 | .628 |
Cohort 3 | |||
 Age (≥ 50 vs. < 50) | 1.021 | 0.405–2.577 | .964 |
 TILs (%) | 0.880 | 0.769–1.007 | .063 |
 TROP2 (H-score) | 1.010 | 1.001–1.020 | .037* |
 TROP2 (high vs. low) | 2.593 | 0.963–7.227 | .069 |